Jacqueline Pomfret Kirby
Public Communications Contact chez CRINETICS PHARMACEUTICALS, INC.
Profil
Jacqueline Pomfret Kirby is currently the Senior Vice President-Corporate Affairs at Crinetics Pharmaceuticals, Inc. She previously worked as the VP-Corporate Affairs & Government Relations at Jazz Pharmaceuticals Plc, the Vice President-Corporate Affairs at Spero Therapeutics, Inc., and the Vice President-Government Affairs at AstraZeneca Pharmaceuticals LP.
Ms. Kirby holds a graduate degree from Harvard University and an undergraduate degree from Boston University.
Postes actifs de Jacqueline Pomfret Kirby
Sociétés | Poste | Début |
---|---|---|
CRINETICS PHARMACEUTICALS, INC. | Public Communications Contact | 01/09/2023 |
Anciens postes connus de Jacqueline Pomfret Kirby
Sociétés | Poste | Fin |
---|---|---|
SPERO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2022 |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Conseiller Juridique Général | 01/01/2015 |
JAZZ PHARMACEUTICALS PLC | Public Communications Contact | - |
Formation de Jacqueline Pomfret Kirby
Boston University | Undergraduate Degree |
Harvard University | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
JAZZ PHARMACEUTICALS PLC | Health Technology |
CRINETICS PHARMACEUTICALS, INC. | Health Technology |
SPERO THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |